通过NCAPD3介导的AKT激活调节前列腺癌的进展
Yi Zhang1, Wanlin Xie1, Xicui Zong2
1College of Life Sciences Nanjing Normal University Nanjing Jiangsu China.
FASEB bioAdvances
|February 7, 2025
概括
非SMC康素II复杂子单元D3 (NCAPD3) 作为前列腺癌 (PCa) 的瘤基因. 它通过通过STAT3和JAK2激活AKT通路来促进PCa的进展,突出了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 尽管治疗进展,前列腺癌 (PCa) 复发率和死亡率仍然很高.
- 了解驱动PCa进展的分子机制对于开发有效疗法至关重要.
- 非SMC康素II复杂子单元D3 (NCAPD3) 参与细胞分裂,但其在PCa中的作用尚未完全理解.
研究的目的:
- 阐明NCAPD3有助于前列腺癌发展和进展的详细机制.
- 研究PCa细胞中NCAPD3调节的分子通路.
- 评估NCAPD3作为前列腺癌的潜在治疗点.
主要方法:
- 使用qRT-PCR,西部斑,IHC和IF进行基因表达分析.
- 通过ChIP-qPCR和双化酶记者测定进行分子相互作用研究.
- 在体外测试 (CCK8,透孔,伤口愈合) 和体内异种移植模型在裸体小鼠.
主要成果:
- 在PCa样本和细胞系中观察到NCAPD3过度表达.
- NCAPD3增强了STAT3的转录活性,增加了JAK2和EZH2水平.
- NCAPD3通过通过JAK2/PI3K和EZH2/NSD2/mTORC2信号来激活AKT通路来促进PCa细胞的增殖和迁移.
结论:
- 在前列腺癌中,NCAPD3作为瘤基因起作用.
- NCAPD3通过激活AKT信号通路来促进PCa的进展.
- 向NCAPD3可能为前列腺癌治疗提供一种新的治疗策略.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K